DICE Therapeutics CEO J Judice's 2022 pay rises 4% to $5.8M
DICE Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 26, 2023
DICE Therapeutics reported fiscal year 2022 executive compensation information on April 26, 2023.
In 2022, three executives at DICE Therapeutics received on average a compensation package of $3.7M, a 12% increase compared to previous year.
Average pay of disclosed executives at DICE Therapeutics
J. Kevin Judice, Chief Executive Officer, received $5.8M in total, which increased by 4% compared to 2021. 85% of Judice's compensation, or $4.9M, was in option awards. Judice also received $300K in non-equity incentive plan and $540K in salary.
Timothy Lu, Chief Medical Officer, received a compensation package of $2.7M, which increased by 34% compared to previous year. 74% of the compensation package, or $2M, was in option awards.
Scott Robertson, Chief Business and Financial Officer, earned $2.7M in 2022, a 12% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2023.